Fingolimod Overcomes Lenalidomide Resistance in Multiple Myeloma by Inducing Ferroptosis
Fingolimod reverses lenalidomide resistance in multiple myeloma cells by suppressing the NRF2/SLC7A11/GPX4 axis and triggering ferroptosis.
Fingolimod reverses lenalidomide resistance in multiple myeloma cells by suppressing the NRF2/SLC7A11/GPX4 axis and triggering ferroptosis.
Researchers have discovered that ADAR1-mediated adenosine-to-inosine RNA editing converts the microRNA miR-3664-5p from a tumor suppressor into an oncogenic driver ...
Promoter hypermethylation suppresses the long non-coding RNA HAND2-AS1 in bladder cancer, while experimental restoration inhibits tumor growth and activates interferon-related ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.